Home›Companies›Healthcare›Guardian BioMedical

Guardian Biomedical Corp.

Develops patient monitoring software for healthcare organizations.

Updated Nov 11, 2026·Latest SEC filing Mar 3, 2026·Suggest an edit

About Guardian BioMedical

Guardian BioMedical is a private company based in Tampa, Florida, incorporated in 2025 in Delaware. It has reported $60,000 raised in one offering on Form D since March 2026.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 21, 2026Mar 3, 2026$60,000of $250K target1$60,000Equity, SAFEsRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Guardian BioMedical's Form D filed Mar 3, 2026.

MM
Manny Manzel
President and director

Sources

  1. SECGUARDIAN BIOMEDICAL CORP. filing history